The store will not work correctly when cookies are disabled.
4-(propylamino)quinoline-6-carbonitrile
ID: ALA4855534
PubChem CID: 146403418
Max Phase: Preclinical
Molecular Formula: C17H13N3
Molecular Weight: 259.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc2nccc(NCc3ccccc3)c2c1
Standard InChI: InChI=1S/C17H13N3/c18-11-14-6-7-16-15(10-14)17(8-9-19-16)20-12-13-4-2-1-3-5-13/h1-10H,12H2,(H,19,20)
Standard InChI Key: BTRLFIVZTHMSKP-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
5.1081 -20.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1069 -21.3318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8150 -21.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8132 -20.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5218 -20.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5226 -21.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2311 -21.7348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9394 -21.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9346 -20.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2255 -20.0985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4008 -20.1043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6930 -19.6959 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2212 -19.2813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9267 -18.8689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9224 -18.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6285 -17.6449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6245 -16.8285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9141 -16.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2062 -16.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2137 -17.6546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 3 0
1 11 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 259.31 | Molecular Weight (Monoisotopic): 259.1109 | AlogP: 3.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 48.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.88 | CX LogP: 3.18 | CX LogD: 2.63 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.78 | Np Likeness Score: -1.56 |
References
1. (2020) Quinoline-based compounds and methods of inhibiting cdk8/19, |